MFN1 and ovarian cancer: Under hypoxic conditions, ovarian cancer cells were found to undergo metabolic reprogramming and activate MFN1-mediated mitochondrial fission, ultimately leading to reduced production of reactive oxygen species (ROS) within the mitochondria and an increase in the survival of such cells [56].